000 02305nam a2200409 i 4500
999 _c282339
_d282339
001 on1100472139
003 OCoLC
005 20190703133055.0
006 m o d f
007 cr |||||||||||
008 190508s2019 dcu o f000 0 eng c
040 _aPUCPR
_beng
_erda
_epn
_cGPO
_dGPO
_dMvI
042 _apcc
043 _an-us---
074 _a1008-I (online)
086 0 _aY 1.1/8:116-51
099 _aY 1.1/8:116-51
110 1 _aUnited States.
_bCongress.
_bHouse.
_bCommittee on Rules,
245 1 0 _aProviding for consideration of the bill (H.R. 986) to provide that certain guidance related to waivers for state innovation under the Patient Protection and Affordable Care Act shall have no force or effect, and providing for consideration of the bill (H.R. 2157) making supplemental appropriations for the fiscal year ending September 30, 2019, and for other purposes :
_breport (to accompany H. Res. 357).
264 1 _a[Washington, D.C.] :
_b[U.S. Government Publishing Office],
_c[2019]
300 _a1 online resource (11 pages).
336 _btxt
337 _bc
_2rdamedia
338 _bcr
_2rdacarrier
490 1 _aReport / 116th Congress, 1st session, House of Representatives ;
_v116-51
500 _a"May 7, 2019."
500 _aCRDP Program record.
588 _aDescription based on online resource; title from PDF title screen (govinfo web site, viewed on May 8, 2019).
776 0 8 _iPrint version:
_aUnited States. Congress. House. Committee on Rules.
_tProviding for consideration of the bill (H.R. 986) to provide that certain guidance related to waivers for state innovation under the Patient Protection and Affordable Care Act shall have no force or effect, and providing for consideration of the bill (H.R. 2157) making supplemental appropriations for the fiscal year ending September 30, 2019, and for other purposes
_w(OCoLC)1101620368
810 1 _aUnited States.
_bCongress.
_bHouse.
_tReport ;
_v116-51.
856 4 0 _3PDF version
_uhttps://purl.fdlp.gov/GPO/gpo120059
856 4 0 _3Text version
_uhttps://purl.fdlp.gov/GPO/gpo120060
050 4 _aKF32
_b.R8 2019q
610 1 0 _aUnited States.
_bCongress.
_bHouse
_xRules and practice.
655 7 _aLegislative materials.
_2lcgft
942 _2sudocs
_c8